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Congenital malformations are single or multiple defects of the 
morphogenesis of organs or body districts identifiable at birth 
or during the intrauterine life. Their global birth prevalence is 
about 2–3%. Both genetic and environmental factors, as well 
as their combination in a multifactorial contest, may induce 
congenital defects. Congenital malformations may be classi-
fied on the basis of clinical, etiologic as well as pathogenetic 
criteria. Relevant diagnostic and therapeutic tools have been 
progressively improving in the last decades, contributing to a 
better identification and a reduction of long-term morbidity and 
mortality of these patients. A correct identification of a congen-
ital defect is the first step in order to offer a helpful genetic coun-
seling to the parental couple. Because of their increasing life 
expectancy, congenital malformations represent today a major 
issue in the health services for the amount of resources they 
need for the requested multidisciplinary assistance.
Keywords: association, blastogenesis, chromosome, counseling, 
gene, imprinting, methylation, phenotype, sequence, syndrome, 
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Introduction
Congenital malformations are defects of morphogenesis of organs 
or body districts, identifiable at birth. Their birth prevalence is 
about 2–3%. Both genetic and environmental factors may induce 
congenital defects. Diagnostic and therapeutic tools have been 
progressively improving in last decades, contributing to better 
identification and reduction of long-term morbidity/mortality. 
Because of their increasing life expectancy, congenital malforma-
tions represent today a major issue for health services regarding 
the amount of resources they need.
Evidence of congenital malformations at birth begins a 
complex clinical process targeted to correct diagnostic definition 
[1,2], clinical and prognostic evaluation, including treatment 
opportunity and genetic counseling. Most congenital malforma-
tion recognize different causes and pathogenetic pathways in spite 
of an identical phenotypic pattern [3,4]. Therefore, diagnostic 
process is often long and difficult and may require long-term 
follow-up including anamnesis, phenotype analysis, imaging and 
laboratory tests.
On the basis of clinical criteria, major malformations are 
morphogenetic defects producing function impairment needing 
medical or surgical treatment; defects not producing function 
impairment and not requiring medical assistance are minor 
malformations (birth prevalence <4%) or phenotypic variants 
(birth prevalence >4%).
On the basis of etiologic criteria (Table I), primary malfor-
mations are morphogenetic defects arising from intrinsic errors 
of developmental process with genetic origin; disruptions 
(secondary) occur when environmental factors interfere with 
otherwise normal developmental process, determining a global 
impairment or specific damages on developmental fields; defor-
mations arise from ab extrinseco mechanical compression during 
fetal development (amniotic bands, twinning, uterine malforma-
tions and masses).
On the basis of pathogenetic criteria, in syndromes, all 
structural defects arise from a single etiologic factor; sequences 
are characterized by a cascade of dysmorphogenetic processes 
originated by a starting event inducing a cascade of secondary 
defects; in associations, different defects are present with higher 
frequency than random expectancy, without evidence of any etio-
logic or pathogenetic correlation; dysplasias are structural defects 
involving specific tissues.
Associations
Genetic or environmental factors may interfere with blastogenetic 
processes, when embryo is a single developmental field, producing 
defects in organs and body districts apparently not related each 
other. Some associations may share a phenotypic overlapping in 
relation to a common etiologic and pathogenetic mechanisms.
Newborns with VACTERLS association show many of the 
defects summarized in the acronym (Vertebral defects, Anorectal 
atresia, Cardiac anomalies, Tracheoesophageal fistula, Esophageal 
atresia, Renal anomalies, Limb defects, Single umbilical artery). 
VACTERLS association is often sporadic with a low recurrence 
risk and is more frequent in the offspring of diabetic mother.
Any kind of congenital malformations in offspring of diabetic 
mother are 2–4 folds more frequent and are inversely correlated 
with the efficacy of maternal control, particularly in the pericon-
ceptional period. Several factors are involved in the pathogenesis 
(hyperglycemia, hyperglycosilation of proteins, chronic hypoxia, 
polyglobulia and lactic acidosis) interfering with blastogenesis, 
inducing abnormalities of the midline structures and symmetric 
organs. The fetus is usually macrosomic in relation to fetal hyper-
insulinemia, sometimes placental microangiopathy may deter-
mine growth restriction.
Sequences
Malformation sequences may depend both on genetic as well as 
environmental factors. Many organs and systems may be contem-
porarily involved in malformation sequences (Table II).
review Article
Congenital malformations
Giovanni corsello & Mario Giuffrè
Dipartimento Materno Infantile, Università degli Studi di Palermo, Palermo, Italy  
Correspondence: Giovanni Corsello, Dipartimento Materno Infantile, Università degli Studi di Palermo, Via Alfonso Giordano, 390127 Palermo, Italy.  

































































26 G. Corsello & M. Giuffrè
  The Journal of Maternal-Fetal and Neonatal Medicine
Pierre Robin sequence is a developmental defect of the jawbone 
and surrounding oro-pharyngeal region (isolated or part of more 
complex syndromes) characterized by microretrognathia, retro-
glossoptosis, cleft palate, swallowing deficit, pharyngeal stenosis 
and respiratory distress.
Potter sequence originates by absence or severe reduction of 
fetal urine output secondary to bilateral kidney agenesis or other 
urinary tract malformations. Urine production deficit determines 
a constantly empty urinary bladder, anhydramnios and a cascade 
mechanism responsible for pulmonary hypoplasia, respiratory 
distress at birth, dismorphic face with flat profile and fetal hypo-
motility with multiple postural deformations.
Prune belly sequence, named after of the characteristic abdom-
inal appearance, is related to different nephro-urologic defects [5]. 
Urethral obstruction is responsible for oligohydramnios, backward 
urine accumulation and parenchymal damage. Hypertrophic and 
excessively dilated bladder interfere with fetal development of 
abdominal wall muscles, diaphragm and testicular migration.
Syndromes
The overall incidence of chromosomal abnormalities is estimated 
of about 1/170 live births. Prevalence at conception is much higher, 
with high rate of embryo-fetal loss (about 50% of spontaneous 
abortions carry chromosomal alterations). Numeric aberrations 
usually have prezygotic origin, if arising from postzygotic errors 
they are present only in a percentage of cells (mosaics). Structural 
aberrations occur de novo from meiotic rearrangements or may 
be inherited from one parent, carrying a balanced chromosomal 
translocation.
Down syndrome (21 trisomy) is the most frequent chromo-
somal aberration at birth (about 1/700). In most cases (95 %), it 
is secondary to a maternal meiotic nondisjunction of homolo-
gous chromosomes 21. Incidence increases with maternal age at 
conception. Neonatal phenotype is characteristic: Brushfield spots, 
upslanting palpebral fissures, epicanthal folds, small nose, small 
mouth with prominent tongue, flat facial profile, brachycephaly, 
flat occipital bone, small low-set ears, short neck with redundant 
skin folds and single palmar crease. Newborns are hypotonic with 
joint laxity. Organ involvement may include congenital heart 




   Polyploidy
   Polysomy
   Monosomy
  Structural
   Deletions
   Duplications
   Insertions
   Translocations
 Monogenic
  Point mutations
   Nonsense
   Missense
   Frameshift
  Dynamic mutations
   Triplet amplification
  Epigenetic regulation
   Imprinting defects





   Cytomegalovirus
   Rubella
   Herpes viruses
  Bacteria
   Treponema pallidum
  Parasites
   Toxoplasma gondi
 Chemical agents
  Drugs
   Antiblastics
   Anticonvulsants
   Antibiotics
  Abuse substances
   Alcohol
   Smoke
   Cocaine
   Opiates
  Metabolic conditions
   Hyperglycemia, hyperinsulinemia
   Hyperphenylalaninemia
   Hyperandrogenism
 Physical agents
  Ionizing radiations
  Electromagnetic radiations
 Vascular disruptions
  Subclavian artery vascular disruption
  Twin-twin disruption sequence
 Mechanical causes (deformations)
  Amniotic bands
  Twinning
  Oligohydramnios
  Uterine malformations
  Uterine tumors
Table II. Main malformation sequences.
Name Developmental field and organs involved
Holoprosencephaly Precordial mesoderm, prosencephalic 
vesicle, rinencephalon, orbits, nose, 
premaxilla
Septo-optic dysplasia Optic chiasm, hypophysis
Pierre Robin Jaw bone, oro-pharyngeal region
CATCH 22 IV brachial arch, II and III brachial 
pouches
Poland Pectoral muscle, superior limb
Klippel–Feil Spine
Potter Kidneys, urinary tract, lungs, limbs, facies
Prune belly Urinary tract, abdominal wall
Bladder-cloacal extrophy Peri-umbilical mesoderm
Rokitanski Muller ducts
Sirenomelia Caudal mesoderm
Caudal regression Caudal mesoderm
Premature rupture of amnios Median axis, limb deformations, facial 
clefts
Fetal akinesia Multiple body districts
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defects, duodenal atresia or stenosis and urinary tract malforma-
tions. Edwards syndrome (18 trisomy) newborns show severe 
prenatal growth restriction, dolicocephaly, prominent occipital 
bone and low-set dysplastic external ears, jaw hypoplasia, flexed 
hands with finger overlapping, talipes with rocker-bottom feet. 
Other malformations are frequent and are responsible for the 
severe prognosis with high neonatal mortality. Patau syndrome 
(13 trisomy) newborns show small trigonocephalic skull, aplasia 
cutis on the scalp, cleft lip and palate, microphthalmia, variable 
hypotelorism up to cyclopia, postaxial polydactyly/syndactyly, 
forced flexion of the fingers, plantar convexity. Other organ 
involvement is frequent. Patients with fully expressed phenotype 
usually die in the first month of life. Turner syndrome is the most 
frequent sex chromosome aneuploidy (1/2500), determined by 
X chromosome monosomy, frequently as mosaic with a milder 
phenotype. Neonatal diagnosis may be suspected by lymphoe-
dema of hands and feet, nail dysplasia, neck pterygium, large 
mouth with downturned corners, dysplastic external ears, left 
heart output defects, prenatal history of cystic hygroma. Clinical 
phenotype modifies with age and other features become evident 
(short stature, short neck, cubitus valgus and gonadal dysgenesis). 
CATCH 22 is an acronym of the main clinical features (Cardiac 
abnormality, Abnormal face, Thymic hypoplasia, Cleft palate, 
Hypoparathyroidism) due to a 22q11.2 deletion. Clinical expres-
sivity is variable depending on the extension of deletion and the 
involved genes [6]. The evidence of neonatal hypocalcaemia and 
craniofacial dysmorphic features (micrognathia, cleft palate, ante-
verted nares and low-set external ears) with a conotruncal heart 
defect and absent thymic shadow at chest X-rays delineates the 
phenotype.
Monogenic disorders are single gene mutations with mende-
lian mode of inheritance. Genotype-phenotype correlation is still 
not defined for many conditions. Each syndrome may be due to 
different mutations in the same gene or in different genes (genetic 
heterogeneity). The same mutation may determine different 
phenotypes (phenotypical variability), even in the same family, 
in relation to the interference of other genetic and/or environ-
mental factors. In addition, there are some epigenetic factors 
acting during the differentiation processes which may modify the 
genic expression, also in relation to the parental origin of the gene 
(genomic imprinting).
Cornelia de Lange syndrome occurs in 1/10,000 newborns 
and is usually sporadic, due to de novo mutations [7]. Newborns 
show a typical face (microbrachycephaly, low anterior and 
posterior hairline, synophrys, small nose with depressed nasal 
bridge, anteverted nares, long philtrum, “carp” mouth, maxil-
lary prognathism, low-set ears), intrauterine and postnatal 
growth restriction, hypertrichosis and upper limb anomalies. 
Additional malformations may be present. Rubinstein–Taybi 
syndrome is characterized by genetic heterogeneity, about 25 
% of patients present mutations or microdeletions in the gene 
encoding the cAMP response element-binding protein [8]. 
Main features are microcephaly, frontal bossing, downslanting 
palpebral fissures, beaked nose, epicanthal folds, strabismus, 
maxillary hypoplasia, high arched palate, external ear abnor-
malities, hand and foot involvement on the I axis and hirsutism. 
Marfan syndrome is determined by heterozygous AD muta-
tions in the FBN1 gene encoding for fibrillin 1 [9]. Newborns 
show arachnodactyly, long and thin limbs, increased length 
joint laxity and hypermobility, muscular hypotonia, hernias, 
pectus carinatum or excavatum. Heart evaluation shows mitral 
valve prolapse and aortic defects. Ocular signs (ectopia lentis, 
early glaucoma) become evident with age. Noonan syndrome 
is a relatively frequent (1/2000) condition due to AD muta-
tions in PTPN11 gene [10]. Newborns show hypertelorism, 
upslanting palpebral fissures, low-set posteriorly rotated ears, 
neck pterygium, shield chest with deformation of the sternum, 
lymphoedema. Heart involvement is at the level of pulmonary 
output. Prader–Willi syndrome is determined by absent expres-
sion of genes with paternal origin in the region 15q11-q13, 
arising from microdeletions of paternal chromosome 15 or 
maternal uniparental disomy (UPD). Methylation test may 
identify almost all patients. Newborns show congenital hypo-
tonia, respiratory and feeding difficulties (tend to improve 
after the neonatal period), hypomimic face, genital hypoplasia 
[11]. Beckwith–Wiedemann syndrome is determined by an 
altered balance between cooperative genes in the region 11p15 
involving imprinted genes encoding for growth factors and 
receptors. Main neonatal features are exomphalos, macro-
glossia and gigantism. Other signs are visceromegaly, adreno-
cortical cytomegaly, auricular indentations, hypoglycemia and 
limb hemihypertrophy. There is an increased risk of malignant 
tumors (Wilms tumor, adrenal carcinoma and hepatoblastoma). 
Silver–Russell syndrome is a sporadic condition with genetic 
heterogeneity involving imprinted genes [12]. Phenotype is 
characterized by prenatal and postnatal growth restriction 
with normal development of the skull (pseudohydrocephalic 
appearance), craniofacial features (triangular shaped face and 
broad forehead), body asymmetry and minor malformations. 
Goldenhar syndrome is a spectrum of malformations involving 
eye, ear and vertebrae (hemifacial microsomia, ipsilateral 
deformity of the external ear, epibulbar dermoid, coloboma 
of the upper eyelid, cervical vertebrae defects) with heteroge-
neous etiology and highly variable phenotype [13]. Its defects 
are more often unilateral and origin from a vascular disrup-
tion of branchial arches. Smith-Lemli-Opitz syndrome is a rare 
autosomal recessive (AR) condition, caused by mutations in 
the steroid-delta-7-reductase gene [14], determining a severe 
deficit of endogenous cholesterol and its derivatives. Newborns 
show intrauterine growth restriction, severe hypotonia, micro-
dolicocephaly, micrognathia, hypovirilization and many other 
features. Failure to thrive and psychomotor delay worsen with 
age.
Disruptions
Congenital malformations can be secondary to exogenous 
factors acting during intrauterine life (Table I), inducing 
abnormalities of developmental processes. Etiologic identifi-
cation (Table III) is important to offer genetic counseling and 
estimate recurrence risk in the family. High IgM level soon after 
birth may strongly predict fetal infection. Any substance intro-
duced in the human organism (drugs, alcohol, smoking, abuse 
substance) or produced by maternal metabolism in specific 
situations may cross placenta, reach the fetus and be dangerous 
for embryo-fetal development. Individual and placental metab-
olism may largely influence clinical effects, dosage and timing 
of administration.
Any vascular accident at early stages of the embryo-fetal 
development may determine subsequent morphogenetic 
defects in the related body districts. Poland sequence includes 
pectoral muscle agenesis and ipsilateral superior limb reduc-
tion defects. Twin-twin disruption sequence is related to the 
intrauterine developmental impairment of a monozygotic twin 
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Dysostoses
It is a heterogeneous group of birth defects with skeletal involve-
ment, due to mutations of genes involved in bone development. 
Classification is based on phenotypic or genetic criteria. Most 
conditions are determined by mutations in fibroblast growth 
factor receptor (FGFR) genes, with string evidence of genetic 
heterogeneity and genic pleiotropism. Genotype/phenotype 
correlation is difficult and can be influenced by other genes 
(epistatic) as well as other interactive cytoplasmatic and envi-
ronmental factors.
Craniofacial dysostoses
Craniosynostoses depend on precocious closure of cranial 
sutures that limits cranial growth, producing a deformation of 
the skull depending on suture involvement (kind, timing, exten-
sion and symmetry). There are many conditions characterized 
by not-syndromal craniosynostoses. Scaphocephaly depends 
on the precocious closure of the sagittal suture with consequent 
restriction of growth along transverse axis and compensa-
tory growth excess along antero-posterior axis. Plagiocephaly 
depends on the precocious closure of only one coronal suture 
with consequent ipsilateral growth restriction and flattening of 
frontal bone. Brachycephaly depends on the precocious closure 
of both coronal sutures with consequent growth restriction 
along antero-posterior axis and compensatory skull develop-
ment in height. Acrocephaly depends on the precocious closure 
of coronal and sagittal sutures with consequent severe growth 
restriction along both antero-posterior and transverse axes and 
compensatory development in frontal region. Trigonocephaly 
depends on the precocious closure of metopic suture with a 
longitudinal bone crest in median frontal region, determining 
a triangular appearance of the skull. Cloverleaf skull is related 
to the precocious closure of coronal, sagittal and lambdoideal 
sutures with excessive skull growth in height and bilaterally 
determining a trilobar appearance. In other newborns, it is 
possible to recognize a specific condition of syndromal cran-
iosynostosis. Apert syndrome newborns show acrocephaly 
(synostosis of coronal sutures), frontal bossing, flat occipital 
bone, exophthalmus, hypertelorism, small upturned nose, 
maxillary hypoplasia, low-set ears and syndactyly of hands and 
feet (spoon shaped hand with bone and nail fusion) due to AD 
de novo FGFR2 mutations [15]. Crouzon syndrome is the most 
frequently reported syndromal craniosynostosis characterized 
by acrocephaly (synostosis of coronal sutures), frontal bossing 
and flat occipital bone, ocular proptosis, small upturned nose, 
maxillary hypoplasia, with no hand and foot involvement, due to 
AD FGFR2 mutations. Muenke syndrome is a common unilat-
eral coronal craniosynostosis with brachydactyly, determined 
by a AD Pro250Arg FGFR3 mutation [16]. Pfeiffer syndrome is 
a rare acrocephalosyndactyly with ocular proptosis, maxillary 
hypoplasia, low-set ears, cloverleaf skull, hand and foot I ray 
hypoplasia, determined by several AD mutations in FGFR1 and 
FGFR2 genes.
Other craniofacial dysostoses are Treacher-Collins syndrome 
characterized by a developmental defect of jaw and facial bones, 
with wide variability, determined by several different mutations 
in the gene codifying for the treacle protein, which has a key role 
in the early craniofacial development [17]; Nager syndrome, a 
sporadic condition with genetic heterogeneity characterized by 
mandibulofacial dysostosis with associated preaxial limb abnor-
malities; Klippel–Feil anomaly, a developmental defect of the 
spine, with possible alterations at cervical, thoracic and lumbar 
level (short neck, pterygium, kyphosis and scoliosis); and limb 
dysostoses, digital defects of one or more contiguous bones, 
whose development pathway is determined by a complex genetic 
Table III. Main disruptions determined by biologic and chemical agents.
 Phenotype
Biologic agent
 Cytomegalovirus Microcephaly, intracranial calcifications, psychomotor delay, sensorineural hearing loss, chorioretinitis, hepatosplenomegaly, 
thrombocytopenia, virus presence in secretions and biologic fluids (urine)
 Rubella virus Microcephaly, psychomotor delay, congenital cataract, sensorineural hearing loss, heart defects, hematologic alterations 
(anemia, thrombocytopenia)
 Varicella-Zoster virus Mental retardation, cortical atrophy, seizures, chorioretinitis, skin scars
 Treponema Pallidum Palmoplantar pemphigus, exanthema with skin scars, anemia, thrombocytopenia, hepatosplenomegaly, miocarditis, 
chorioretinitis, muco-haematic rhinitis, skeletal alterations (lacunae, caput quadratum, metaphyseal ossification defects, 
osteochondrites and secondary pseudoparalises)
 Toxoplasma Gondi Hydrops, hydrocephalus, intracranial calcifications, chorioretinitis, cataract, seizures, hepatosplenomegaly, skin rush
Chemical agent
 Anticonvulsant drugs Cleft lip and palate, neural tube defects, congenital heart defects
 Hydantoin (microcephaly, mental retardation, CNS abnormalities, small nose, facial bone hypoplasia, epichantus, 
hypertelorism, strabismus, cleft lip and palate, micrognathia, short neck, heart defects)
 Trimethadione (microcephaly, facial bone hypoplasia, palpebral synophrys, epichantus, external ear dysplasia, urogenital 
defects, heart defects)
 Valproic acid (trigonocephaly, reduced bitemporal diameter, facial bone hypoplasia, small nose, cleft lip and palate, 
urogenital and limb defects)
 Alcohol IUGR, peculiar face (microcephaly, short palpebral fissures, small nose with anteverted nares, hypoplasic nasal philtrum, 
microretrognathia), neurologic abnormalities (hypotonia, seizures, poor motor coordination, mental retardation)
 Cocaine Prematurity, IUGR, microcephaly, urogenital and skeletal malformations
 Heroin IUGR, low birth weight, congenital malformations
 Maternal diabetes Macrosomia, hypoglycemia, hypocalcaemia, ventricular septal hypertrophy, caudal dysgenesis, any kind of congenital 
malformations (skeletal, cardiac, renal, intestinal, CNS...)
 Maternal  
 hyperphenylalaninemia
Defects of cellular proliferation and migration with myelinization delay (IUGR, severe microcephaly, hypotelorism, 
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system, phylogenetically common to most of vertebrates (poly-
dactyly, syndactyly, symphalangism, brachydactyly, ectrodactyly 
and oligodactyly).
Osteochondrodysplasias
It is a wide and heterogeneous group of genetically determined 
conditions, involving the development of osseous and cartilagi-
nous tissues. Their overall prevalence at birth is about 1/5000, 
secondary to a sensible reduction in the last decades with prenatal 
diagnosis for most severe conditions. Classification is based on 
phenotypical evidences, modified by the molecular diagnostic 
opportunities upon the genes of collagen, elastin, FGFR, carti-
laginous proteins, vitamin D receptor, lysosomal and peroxisomal 
enzymes.
Lethal osteochondrodysplasias are characterized by general-
ized involvement and early mortality related to respiratory failure. 
Milder osteochondrodysplasias may benefit from surgical bone 
enlongement and other corrective surgery and rehabilitation 
programs.
Achondroplasia is the most common cause of disharmonic 
short stature with short limbs (megalencephaly, frontal bossing, 
depressed nasal bridge, facial bone hypoplasia, prognatism, 
narrow thorax, rhizomelic short limb dwarfism, brachydactyly, 
trident hands and hypotonia), determined by AD Gly380Arg 
mutation in FGFR3 gene, with a high de novo mutation rate 
related with advanced paternal age. Thanatophoric dwarfism is 
a severe bone dysplasia (micromelic dwarfism with bowing of 
long bones, telephone receiver femurs, narrow thorax, severe 
platyspondily, facial bone hypoplasia and craniosynostosis) with 
high perinatal lethality, due to a de novo AD mutation in FGFR3 
gene. Campomelic dwarfism is a severe bone dysplasia with high 
perinatal lethality and female prevalence, due to AR mutations in 
SOX9 gene. The phenotype includes sex reversal, macrocephaly, 
large fontanels, micrognathia, short neck, pectus carinatum, short 
limb dwarfism, talipes, anterior bowing of tibiae and poor ossifi-
cation signs [18]. Diastrophic dysplasia is a rare condition due to 
AR mutations in SLC26A2 gene. Newborns show rhizomelic short 
limb dwarfism, bilateral clubbed foot, premature calcification of 
the costal cartilages, kyphoscoliosis, hip contractures, cleft palate 
and “hitchhiker” thumb due to deformity of the first metacarpal. 
Osteogenesis imperfecta is a genetically (type 1 collagen genes) 
and phenotypically (four different clinical variants) heteroge-
neous group of conditions characterized by frequent bone frac-
tures [19]. Osteodysplastic primordial dwarfism is a brachymelic 
microcephalic dwarfism (prominent eyes, microretrognathia, 
high arched palate, oligodontia, sparse scalp hair, pectus cari-
natum, multiple skeletal abnormalities and sensory defects) with 
likely genetic heterogeneity and AR inheritance.
Genetic counseling and prenatal diagnosis
The improvement of knowledge and applications in biomedical 
sciences has contributed to the relevant advances in the preven-
tion and early detection of genetic diseases. The most important 
tool for prevention is the genetic counseling, a nondirective 
communication/information process to the family in order to 
adopt conscious, responsible and coherent choices in dealing with 
genetic disease patients. Therefore, it is very important to achieve 
a confirmed diagnosis and up-to-date knowledge of natural 
history, prognostic and therapeutic implications, inheritance, 
recurrence risk and diagnostic opportunities (prenatal). Index 
case in the family as well as other risk factors (consanguinity, 
advanced maternal age, recurrent abortions, mutation carrier) 
require genetic counseling. Recurrence risk for multifactorial 
diseases may be given on the basis of empirical methods while 
in case of monogenic diseases (mendelian inheritance, genomic 
imprinting…) it can be estimated and communicated together 
with the available opportunities of genetic diagnosis.
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